Benefit of Adding Panitumumab to FOLFOX4 in Patients with KRAS/NRAS Wild-Type (WT) Metastatic Colorectal Cancer (mCRC): A Number-Needed-To-Treat (NNT) Analysis

✍ Scribed by Douillard, J.Y.; Sienna, S.; Davison, C.; Braun, S.; Sidhu, R.

• Book ID: 122327059
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 61 KB
• Volume: 16
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2013.08.418